Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Lederman

Showing results (221-230 of 303) with videos related to

Pageof 31
Sort By:
The Journal of Infectious Diseases|October 17, 2006
A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086Constance A Benson, Florin Vaida, Diane V Havlir, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 3, 2015
Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV InfectionCarey L Shive, Brian Clagett, Marie R McCausland, et al.
Vaccine|December 20, 2017
Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infectionCarey L Shive, Chelsey J Judge, Brian Clagett, et al.
JAMA Network Open|December 3, 2019
Association of Lymphopenia With Risk of Mortality Among Adults in the US General PopulationDavid A Zidar, Sadeer G Al-Kindi, Yongmei Liu, et al.
Pathogens & Immunity|August 29, 2020
Pathogenesis of Aging and Age-related Comorbidities in People with HIV: Highlights from the HIV ACTION WorkshopDana Gabuzda, Beth D Jamieson, Ronald G Collman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2013
Discordance between peripheral and colonic markers of inflammation during suppressive ARTRichard M Dunham, Ivan Vujkovic-Cvijin, Steven A Yukl, et al.
Pathogens & Immunity|March 20, 2024
Erratum to: Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?Justin Harper, Michael R Betts, Mathias Lichterfeld, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter StudiesRodolphe Thiébaut, Ana Jarne, Jean-Pierre Routy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 11, 2003
A study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm(-3)Robert S Wallis, Robert Kalayjian, Jeffrey M Jacobson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
Role of Baseline pol Genotype in HIV-1 Fitness EvolutionJan Weber, Hector R Rangel, Bikram Chakraborty, et al.
Pageof 31

Showing results (221-230 of 303) with videos related to

Sort By:
Pageof 31
The Journal of Infectious Diseases|October 17, 2006
A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086Constance A Benson, Florin Vaida, Diane V Havlir, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 3, 2015
Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV InfectionCarey L Shive, Brian Clagett, Marie R McCausland, et al.
Vaccine|December 20, 2017
Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infectionCarey L Shive, Chelsey J Judge, Brian Clagett, et al.
JAMA Network Open|December 3, 2019
Association of Lymphopenia With Risk of Mortality Among Adults in the US General PopulationDavid A Zidar, Sadeer G Al-Kindi, Yongmei Liu, et al.
Pathogens & Immunity|August 29, 2020
Pathogenesis of Aging and Age-related Comorbidities in People with HIV: Highlights from the HIV ACTION WorkshopDana Gabuzda, Beth D Jamieson, Ronald G Collman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2013
Discordance between peripheral and colonic markers of inflammation during suppressive ARTRichard M Dunham, Ivan Vujkovic-Cvijin, Steven A Yukl, et al.
Pathogens & Immunity|March 20, 2024
Erratum to: Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?Justin Harper, Michael R Betts, Mathias Lichterfeld, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter StudiesRodolphe Thiébaut, Ana Jarne, Jean-Pierre Routy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 11, 2003
A study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm(-3)Robert S Wallis, Robert Kalayjian, Jeffrey M Jacobson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
Role of Baseline pol Genotype in HIV-1 Fitness EvolutionJan Weber, Hector R Rangel, Bikram Chakraborty, et al.
Pageof 31